JENNIFER WALKER: Open Payments
NPI 1104185180 · HOLLADAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 59 payments from 14 companies in 2025. Trend: 2023 $1,195 · 2024 $1,643 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $272 |
| Janssen Biotech, Inc. | 4 | $272 |
| ABBVIE INC. | 17 | $171 |
| GENZYME CORPORATION | 1 | $122 |
| Organon LLC | 4 | $109 |
| UCB, Inc. | 3 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $94 |
| Arcutis Biotherapeutics, Inc. | 1 | $88 |
| PFIZER INC. | 5 | $87 |
| Galderma Laboratories, L.P. | 2 | $37 |
Products named: TREMFYA, COSENTYX, SKYRIZI, DUPIXENT, Bimzelx, SPEVIGO, NEXPLANON, Zoryve.
Industry payments across UT — which companies pay providers there.
